comparemela.com

Latest Breaking News On - குறி பரிசோதனை - Page 1 : comparemela.com

F Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art 53 LR] Roche reports good half-year results

F Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art 53 LR] Roche reports good half-year results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

BioMark Diagnostics, Inc : Biomark to Expand Treatment Response Trial to Advanced Lung Cancer Patients Receiving Immunotherapy

BioMark Diagnostics, Inc : Biomark to Expand Treatment Response Trial to Advanced Lung Cancer Patients Receiving Immunotherapy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Influenza Testing Market Size, Share, Industry by Global Major Companies Profile and Key Regions 202

DBMR published a research report on “Influenza Testing Market 2021 Industry Analysis, Size, Share, Growth, Trends and Forecast to 2027. Influenza Testing Market report provides analysis of top players in all regions with industry size, growth, technology, market insights, demand, trend, key statistics and industry f.

BioMark Diagnostics, Inc : BioMark Receives $825K Grant to Develop Its Liquid Biopsy Assay for Lung Cancer Screening

BioMark Announces Change of Auditor | MarketScreener

Message : Required fields Vancouver, British Columbia (Newsfile Corp. - May 31, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ( BioMark ) announces that it has changed its auditors from Manning Elliott LLP ( Former Auditor ) to PricewaterhouseCoopers LLP ( Successor Auditor ). The Former Auditor resigned as the auditor of the Company effective May 17 th, 2021 and the board of directors of the Company appointed the Successor Auditor effective as of the same date, until the next Annual General Meeting of the Company. There were no reservations in the Former Auditor s audit report for the relevant period, being the two most recently completed financial years ended March 31, 2020. In accordance with National Instrument 51-102 - Continuous Disclosure Obligations ( NI 51-102 ), the Company has filed a Change of Auditor Notice (the Notice ) on SEDAR together with letters from both the Former Auditor and Successor Auditor, with each letter confirming agreem

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.